Catherine Shanahan has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reply to Najjar, R.S. Myths of the Low-Carbohydrate Diet “Myths”. Comment on “Teicholz et al. Myths and Facts Regarding Low-Carbohydrate Diets. Nutrients 2025, 17, 1047”

    by Nina Teicholz, Steven M. Croft, Ignacio Cuaranta, Mark Cucuzzella, Mariela Glandt, Dina H. Griauzde, Karen Jerome-Zapadka, Tro Kalayjian, Kendrick Murphy, Mark Nelson, et al.

    We note that the names of the commenters were not disclosed to us when we prepared this response

  • Open Access

    Cooking Oil-Derived Aldehydes: Overlooked Components of the Western Diet with the Potential to Disrupt Fetal Brain Development

    by Catherine Shanahan, Martin Grootveld

    Dietitians routinely recommend refined high polyunsaturated fatty acid (PUFA) content culinary oils such as soybean, corn, canola, rapeseed and sunflower oils to pregnant women. Unfortunately, these PUFAs readily undergo peroxidation (especially at high frying or cooking temperatures), generating toxic lipid oxidation products, including reactive aldehydes and oxidized lipid mediators with established biological activities that may negatively impact fetal brain development. This hypothesis-driven perspective paper proposes a conceptual framework linking the maternal consumption of oils contaminated with lipid oxidation products to fetal neurodevelopmental vulnerability. We also identify key research priorities, including improved exposure assessments, the development of reliable aldehyde and other oxylipin biomarkers, and controlled dietary intervention studies. Such investigations will help clarify whether these commonly consumed culinary oils meaningfully contribute to the increasing rates of adverse neurodevelopmental outcomes.

  • Open Access

    The energy model of insulin resistance: A unifying theory linking seed oils to metabolic disease and cancer

    by Catherine Shanahan

    The problem of insulin resistance has exploded in recent decades, from practically nonexistent in 1950, to nearly ubiquitous today. Despite this, the dietary origins of insulin resistance remain elusive. Many have identified the Western Diet, focusing on saturated fat. However, population-scale consumption data shows that our consumption of saturated fat has remained unchanged, while our consumption of polyunsaturated fats has increased by more than 300%. This paper discusses the primary source of those polyunsaturated fatty acids (PUFA), a collection of eight chemically similar refined, bleached, and deodorized (RBD) seed oils, i.e., soy and canola, that now, together, represent the number one source of calories in the United States today, or approximately 30 percent of the average person’s daily intake. The Energy Model of Insulin Resistance hypothesizes that RBD seed oil consumption can promote cellular oxidative stress, forcing cells to change their fueling strategy to reduce oxidative stress. This is accomplished by increasing aerobic glycolysis to minimize fat oxidation. Observed in both cancerous and insulin resistance cells, aerobic glycolysis is also known as the Warburg Effect. While beneficial to individual cells, at the whole-organism level, it disrupts intravascular glucose homeostasis, ultimately elevating insulin and counter-regulatory hormones (CRH) simultaneously. CRH oppose the insulin signal, leading to the phenotype of insulin resistance. In summary, the Energy Model of Insulin Resistance provides a framework for understanding that the primary metabolic deficit in people with insulin resistance may not be abnormal insulin signaling, but rather an abnormally increased metabolic demand for sugar. If correct, this would elucidate the mitochondrial origins of the Warburg Effect and suggest that avoiding RBD oils represents an important and understudied dietary strategy for addressing insulin resistance and cancer.


  • Open Access

    Myths and Facts Regarding Low-Carbohydrate Diets

    by Nina Teicholz, Steven M. Croft, Ignacio Cuaranta, Mark Cucuzzella, Mariela Glandt, Dina H. Griauzde, Karen Jerome-Zapadka, Tro Kalayjian, Kendrick Murphy, Mark Nelson, et al.

    As the prevalence of chronic diseases persists at epidemic proportions, health practitioners face ongoing challenges in providing effective lifestyle treatments for their patients. Even for those patients on GLP-1 agonists, nutrition counseling remains a crucial strategy for managing these conditions over the long term. This paper aims to address the concerns of patients and practitioners who are interested in a low-carbohydrate or ketogenic diet, but who have concerns about its efficacy, safety, and long-term viability. The authors of this paper are practitioners who have used this approach and researchers engaged in its study. The paper reflects our opinion and is not meant to review low-carbohydrate diets systematically. In addressing common concerns, we hope to show that this approach has been well researched and can no longer be seen as a “fad diet” with adverse health effects such as impaired renal function or increased risk of heart disease. We also address persistent questions about patient adherence, affordability, and environmental sustainability. This paper reflects our perspective as clinicians and researchers engaged in the study and application of low-carbohydrate dietary interventions. While the paper is not a systematic review, all factual claims are substantiated with citations from the peer-reviewed literature and the most rigorous and recent science. To our knowledge, this paper is the first to address potential misconceptions about low-carbohydrate and ketogenic diets comprehensively.